WallStreetZenWallStreetZen

NASDAQ: CMRX
Chimerix Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CMRX

Based on 2 analysts offering 12 month price targets for Chimerix Inc.
Min Forecast
$6.00+516.65%
Avg Forecast
$8.50+773.59%
Max Forecast
$11.00+1,030.52%

Should I buy or sell CMRX stock?

Based on 2 analysts offering ratings for Chimerix Inc.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CMRX stock forecasts and price targets.

CMRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-08-17
lockedlocked$00.00+00.00%2023-08-16

1 of 1

Forecast return on equity

Is CMRX forecast to generate an efficient return?
Company
N/A
Industry
-0.69%
Market
30.42%

Forecast return on assets

Is CMRX forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.27%

CMRX revenue forecast

What is CMRX's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$407.0k-64.11%
Avg 2 year Forecast
$30.0M+2,545.5%
Avg 3 year Forecast
$7.0M+517.28%
CMRX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CMRX revenue growth forecast

How is CMRX forecast to perform vs Biotechnology companies and vs the US market?
Company
144.44%
Industry
34.77%
Market
7.57%
CMRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CMRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CMRX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CMRX$0.97$8.50+773.59%Buy
SGMT$4.04$43.67+980.87%Strong Buy
IOBT$1.31$8.33+536.11%Strong Buy
MNOV$1.75N/AN/A
MDWD$9.27$31.00+234.41%Buy
View Top Biotech Stocks

Chimerix Stock Forecast FAQ

Is Chimerix Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: CMRX) stock is to Buy CMRX stock.

Out of 2 analysts, 0 (0%) are recommending CMRX as a Strong Buy, 2 (100%) are recommending CMRX as a Buy, 0 (0%) are recommending CMRX as a Hold, 0 (0%) are recommending CMRX as a Sell, and 0 (0%) are recommending CMRX as a Strong Sell.

If you're new to stock investing, here's how to buy Chimerix stock.

What is CMRX's revenue growth forecast for 2023-2025?

(NASDAQ: CMRX) Chimerix's forecast annual revenue growth rate of 144.44% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.77%, and it is also forecast to beat the US market's average forecast revenue growth rate of 7.57%.

Chimerix's revenue in 2023 is $1,134,000.On average, 4 Wall Street analysts forecast CMRX's revenue for 2023 to be $36,178,759, with the lowest CMRX revenue forecast at $27,556,303, and the highest CMRX revenue forecast at $59,646,062. On average, 2 Wall Street analysts forecast CMRX's revenue for 2024 to be $2,666,739,000, with the lowest CMRX revenue forecast at $2,666,739,000, and the highest CMRX revenue forecast at $2,666,739,000.

In 2025, CMRX is forecast to generate $622,239,100 in revenue, with the lowest revenue forecast at $444,456,500 and the highest revenue forecast at $800,021,700.

What is CMRX's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: CMRX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.27%.

What is CMRX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CMRX price target, the average CMRX price target is $8.50, with the highest CMRX stock price forecast at $11.00 and the lowest CMRX stock price forecast at $6.00.

On average, Wall Street analysts predict that Chimerix's share price could reach $8.50 by Aug 17, 2024. The average Chimerix stock price prediction forecasts a potential upside of 773.59% from the current CMRX share price of $0.97.

What is CMRX's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: CMRX) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.